Valens Announces Revenue Guidance for Fourth Quarter 2019 and Intention to Commence a Normal Course Issuer Bid
Valens Establishes Operations in the Greater Toronto Area with the Acquisition of a Leading Beverage Company
Valens and BRNT Enter into Major White Label Deal with a Gross Revenue Potential to Valens of More Than $50 Million
Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019
Valens Receives Amended License from Health Canada Permitting Sales Directly to Provinces and Territories & Provides Operational Update
Valens Becomes First Third Party Processor to Enter Strategic Agreement with Shoppers Drug Mart to Supply Cannabis Oil Products
Valens Announces 5 Year White Label Cannabis Infused Beverage Contract with Iconic Brewing Company’s Cannabis Division
Valens Announces Guidance for Record Q3 2019 Revenue and Participation in Live Investor Webcast on September 12th
